Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2026-01-16 @ 1:48 AM
Study NCT ID:
NCT01893320
Status:
COMPLETED
Last Update Posted:
2022-02-09
First Post:
2013-07-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Leukemia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Leukemia | View |
| None | Acute Myeloid Leukemia | View |
| None | AML | View |
| None | High-risk Myelodysplastic Syndrome | View |
| None | MDS | View |
| None | Chronic Myelomonocytic Leukemia | View |
| None | CMM | View |
| None | Maximum tolerated dose | View |
| None | MTD | View |
| None | Vosaroxin | View |
| None | Decitabine | View |
| None | Dacogen | View |